journal article·2015-05-13

Enhancement of VEGF-Mediated Angiogenesis by 2-N,6-O-Sulfated Chitosan-Coated Hierarchical PLGA Scaffolds

Yuanman Yu, Jie Chen, Rui Chen, Lingyan Cao, Wei Tang, Dan Lin, Jing Wang, Changsheng Liu

Publisher page

Abstract

Rapid and controlled vascularization within scaffolds remains one of the key limitations in tissue engineering applications. This study describes the fabrication and characterization of 2-N,6-O-sulfated chitosan (26SCS)-coated hierarchical scaffold composed of poly(lactic-co-glycolic acid) (PLGA) microspheres, as a desirable vehicle for vascular endothelial growth factor (VEGF) delivery and consequent angiogenic boosting in vitro. Owing to the hierarchical porous structure and high affinity between VEGF and 26SCS, the 26SCS-modified PLGA (S-PLGA) scaffold possesses excellent entrapment and sustained release of VEGF. Using human umbilical vein endothelial cells (HUVECs) as a cell model, the VEGF-loaded S-PLGA scaffold shows desirable cell viability and attachment. The bioactivity of released VEGF is validated by intracellular nitric oxide secretion and capillary tube formation, demonstrating the improved capacity of VEGF-mediated pro-angiogenesis ascribed to 26SCS incorporation. Such a strategy will afford an effective method to prepare a scaffold with promoted angiogenesis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The State Key Laboratory of Bioreactor Engineering, ‡Key Laboratory for Ultrafine Materials of Ministry of Education, §Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, People’s Republic of China

Funding

Program for New Century Excellent Talents in University · Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (38)

Show source-provided references
1. Tonnesen M. G. · J. Invest. Dermatol. Symp. Proc. · 2000 · 5 · 4010.1046/j.1087-0024.2000.00014.x ↗
2. Baiguera S. · Angiogenesis · 2013 · 16 · 110.1007/s10456-012-9307-8 ↗
3. Griffith L. G. · Science · 2002 · 295 · 100910.1126/science.1069210 ↗
4. Ko H. C. H. · Eur. Cells Mater. · 2007 · 14 · 110.22203/eCM.v014a01 ↗
5. Lee K. Y. · J. Controlled Release · 2003 · 87 · 4910.1016/S0168-3659(02)00349-8 ↗
6. Sun G. · Biomaterials · 2011 · 32 · 9510.1016/j.biomaterials.2010.08.091 ↗
7. Chen Y.-C. · ACS Appl. Mater. Interfaces · 2014 · 6 · 2190610.1021/am5071865 ↗
8. O’Brien F. J. · Biomaterials · 2005 · 26 · 43310.1016/j.biomaterials.2004.02.052 ↗
9. Zheng W. · Adv. Healthcare Mater. · 2013 · 2 · 9510.1002/adhm.201200104 ↗
10. Ferrara N. · Endocr. Rev. · 1997 · 18 · 410.1210/edrv.18.1.0287 ↗
11. Ferrara N. · Nat. Med. · 1998 · 4 · 33610.1038/nm0398-336 ↗
12. Tayalia P. · Adv. Mater. · 2009 · 21 · 326910.1002/adma.200900241 ↗
13. Lazarous D. F. · Circulation · 1996 · 94 · 107410.1161/01.CIR.94.5.1074 ↗
14. Huang M. · Biomacromolecules · 2007 · 8 · 160710.1021/bm061211k ↗
15. Chung Y.-I. · J. Controlled Release · 2010 · 143 · 28210.1016/j.jconrel.2010.01.010 ↗
16. Carmeliet P. · Nat. Med. · 1999 · 5 · 49510.1038/8379 ↗
17. Gerhardt H. · J. Cell Biol. · 2003 · 161 · 116310.1083/jcb.200302047 ↗
18. Singh S. · Biomaterials · 2011 · 32 · 205910.1016/j.biomaterials.2010.11.038 ↗
19. Rostambeigi N. · Am. Surg. · 2011 · 77 · 153910.1177/000313481107701147 ↗
20. Brandner B. · Biochem. Biophys. Res. Commun. · 2006 · 340 · 83610.1016/j.bbrc.2005.12.079 ↗
21. Gitay-Goren H. · J. Biol. Chem. · 1992 · 267 · 609310.1016/S0021-9258(18)42666-X ↗
22. Hasan J. · Clin. Cancer Res. · 2005 · 11 · 817210.1158/1078-0432.CCR-05-0452 ↗
23. Liu H. · Nat. Prod. Rep. · 2009 · 26 · 31310.1039/b819896a ↗
24. Cao L. · Biomaterials · 2014 · 35 · 68410.1016/j.biomaterials.2013.10.005 ↗
25. Anderson J. M. · Adv. Drug Delivery Rev. · 2012 · 64 · 7210.1016/j.addr.2012.09.004 ↗
26. Jain R. A. · Biomaterials · 2000 · 21 · 247510.1016/S0142-9612(00)00115-0 ↗
27. Wang Z. · Pharm. Res. · 2009 · 26 · 116210.1007/s11095-009-9837-y ↗
28. van de Weert M. · Pharm. Res. · 2000 · 17 · 115910.1023/A:1026498209874 ↗
29. Zhou H. J. · Biomaterials · 2009 · 30 · 171510.1016/j.biomaterials.2008.12.016 ↗
30. Fisher J. P. · Biomacromolecules · 2015 · 16 · 43710.1021/bm501853s ↗
31. Ono K. · Glycobiology · 1999 · 9 · 70510.1093/glycob/9.7.705 ↗
32. Vacharathit V. · Biomaterials · 2011 · 32 · 372110.1016/j.biomaterials.2010.12.048 ↗
33. Loh Q. L. · Tissue Eng., Part B · 2013 · 19 · 48510.1089/ten.teb.2012.0437 ↗
34. Causa F. · Biomaterials · 2007 · 28 · 509310.1016/j.biomaterials.2007.07.030 ↗
35. Wei Y. · Biomaterials · 2013 · 34 · 258810.1016/j.biomaterials.2012.12.036 ↗
36. Hoshi R. A. · Biomaterials · 2013 · 34 · 3010.1016/j.biomaterials.2012.09.046 ↗
37. Olsson A.-K. · Nat. Rev. Mol. Cell Biol. · 2006 · 7 · 35910.1038/nrm1911 ↗
38. Ulissi Z. W. · Nano Lett. · 2014 · 14 · 488710.1021/nl502338y ↗